Brooklyn Investment Group’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,267
Closed -$125K 755
2025
Q2
$125K Buy
1,267
+1,060
+512% +$100K 0.02% 824
2025
Q1
$19.2K Sell
207
-3
-1% -$277 ﹤0.01% 1191
2024
Q4
$19.1K Buy
210
+13
+7% +$1.19K 0.01% 770
2024
Q3
$19K Buy
+197
New +$19.2K 0.01% 657

Other funds holding AMED

Brooklyn Investment Group's AMED Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 1,267 shares — an estimated $125K sold.

Brooklyn Investment Group first reported a position in AMED in Q3 2024 and held it in 4 quarters. The position peaked at $125K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 1,267 Amedisys shares in Q3 2025, an estimated $125K.
  • Brooklyn Investment Group first reported a position in Amedisys in Q3 2024 and held it in 4 quarters.
  • Brooklyn Investment Group's Amedisys position peaked at $125K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.